More companies than ever before are training their sights on developing treatments for epilepsy, which affects about 3 million adults and half a million children in the U.S.
Though there are a number of anti-seizure drugs on the market, more than 30% of people with the condition have tried at least three different drugs and still experience seizures.
Create a display name to comment
This name will appear with your comment
